Costly Imported Medicines Leave Patients Vulnerable - Pacific Research Institute

Costly Imported Medicines Leave Patients Vulnerable

health 13983450163 4ed837247f o

Canadians pay less for brand-name medicines because their government levies strict price controls on them. Those price controls force patients to endure severe trade-offs, including drug shortages and long waits for access to the most innovative therapies.

Texas just became the latest state to look north for lower drug prices.

As of the beginning of this month, the state’s Health and Human Services Commission gained authority to contract with Canadian wholesalers and suppliers to import prescription drugs from our northern neighbor.

The prices of brand-name prescription drugs are typically lower in Canada than in the United States. Proponents of drug importation intuitively argue that it will save U.S. patients money.

But the reality is more complex.

Read the full article at Newsmax

Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.

Scroll to Top